ORGANIC
LETTERS
XXXX
Vol. XX, No. XX
000–000
Multicomponent Synthesis of 1‑Aryl
1,2,4-Triazoles
Annie Tam, Ian S. Armstrong, and Thomas E. La Cruz*
Chemical Development, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick,
New Jersey 08903, United States
Received May 20, 2013
ABSTRACT
A multicomponent (single reactor) process for the synthesis of 1-aryl 1,2,4-triazoles was explored and developed. This transformation prepared
the 1,2,4-triazole directly from anilines, amino pyridines, and pyrimidines. The reaction scope was explored with 21 different substrates, and the
position of the nitrogen atoms in the newly formed ring was established by 15N labeling and NMR spectroscopy.
1,2,4-Triazoles are a class of heterocycles found in a wide
range of biologically active molecules encompassing sev-
eral therapeutic areas, and as subunits of coordination
polymers.1,3d
Several methodologies to prepare this important motif
have been reported and reviewed in the literature.2,3d
Common methods to access aryl 1,2,4-triazoles include
the formation and condensation ofa hydrazine derivative,3
transition metal mediated CꢀN bond coupling,4,5 and
SNAr-type chemistry of a halogenated arene with a 1,2,4-
triazole nucleophile.6 Some limitation of these approaches
include multiple steps to generate and activate the hydra-
zine for cyclization, or in the case of SNAr chemistry,
a mixture of N-regioisomers can be formed.6,7 General
(1) Reviews on uses of 1,2,4-triazoles: (a) Al-Masoudi, A.; Al-Soud,
Y. A.; Al-Salihi, N. J.; Al-Masoudi, N. A. Chem. Heterocycl. Compd.
2006, 42, 1377–1403. (b) Pibiri, I.; Buscemi, S. Current Bioactive
Compounds 2010, 6, 208–242. (c) Sahoo, S.; Veliyath, S. K.; Mahendra
Kumar, C. B. Int. J. Res. Pharm. Sci. 2012, 3, 326–333. (d) Shalini, K.;
Kumar, N.; Drabu, S.; Sharma, P. K.; Beilstein J. Org. Chem. 2011, 7,
668–677. (e) Naik, A. D.; Dırtu, M. M.; Railliet, A. P.; Marchand-
Brynaert, J.; Garcia, Y. Polymer 2011, 3, 1750–1775. (f) Klingele, M. H.;
Brooker, S. Coord. Chem. Rev. 2003, 241, 119–132. (g) Haasnoot, J. G.
Coord. Chem. Rev. 2000, 200ꢀ202, 131–185 and references therein.
(2) Reviews on the preparation of 1,2,4-triazoles: (a) Moulin, A.;
Bibian, M.; Blayo, A.-L.; El Habnouni, S.; Martinez, J.; Fehrentz, J.-A.
Chem. Rev. 2010, 110, 1809–1827. (b) Yet, L. Prog. Heterocycl. Chem.
2011, 23, 231–266. (c) Curtis, A. D. M. Sci. Synth. 2004, 13, 603–639.
(d) Holm, S. C.; Straub, B. F. Org. Prep. Proc. Int. 2011, 43, 319–347.
(3) For an elegant synthesis of fully substituted 1,2,4-triazoles with
hydrazines, see: (a) Staben, S. T.; Blaquiere, N. Angew. Chem., Int. Ed.
2010, 49, 325–328. (b) Castanedo, G. M.; Seng, P. S.; Blaquiere, N.;
Trapp, S.; Staben, S. T. J. Org. Chem. 2011, 76, 1177–1179. (c) An
elegant copper catalyzed approach to 1,2,4-triazoles: Xu, H.; Jiang, Y.;
Fu, H. Synlett 2013, 24, 125–129. (d) Guru, M. M.; Punniyamurthy, T.
J. Org. Chem. 2012, 77, 5063–5073 and references therein. (e) Terauchi,
J.; Koike, T.; Honda, E.; Nakamura, M.; Kajita, Y.; Hoashi, Y.;
Morimoto, S.; Fujimoto, T. Preparation of Piperazines and Related
Compounds for Inhibiting Amyloid-β Production. PCT Int. Appl.,
2011002067.
(4) For an example of C-N coupling metal-mediated synthesis of
fused 1,2,4-triazoles from amino pyridines, see: Ueda, S.; Nagasawa, H.
J. Am. Chem. Soc. 2009, 131, 15080–15081.
(5) For examples of metal-mediated CꢀN bond coupling with
symmetrical 1,2,4-triazole and aryl halides, see: (a) Antilla, J. C.;
Baskin, J. M.; Barder, T. E.; Buchwald, S. L. J. Org. Chem. 2004, 69,
5578–5587. (b) Yang, K.; Qiu, Y.; Zheng, Li, Z.; Wang, Z.; Jiang, S.
J. Org. Chem. 2011, 76, 3151–3159. (c) Albrecht, B. K.; Gehling, V. S.;
Hewitt, M. C.; Taylor, A. M.; Harmange, J.-C. Preparation of 4H-
Benzo[b][1,2,4]Triazolo[4,3-d][1,4]Diazepine Derivatives as Bromodo-
main Inhibitors. PCT Int. Appl., 2012151512. (d) Aspnes, G. E.; Didiuk,
M. T.; Filipski, K. J.; Guzman-Perez, A.; Lee, E. C. Y.; Pfefferkorn,
J. A.; Stevens, B. D.; Tu, M. M. Preparation of 3-[4-(Heterocyclyl-
Substituted)-Benzamido]Propanoic Acids as Glucagon Receptor Modula-
tors. U.S. Pat. Appl., 20120202834.
(6) SNAr: (a) De Cleyn, M. A. J.; Van Brandt, S. F. A.; Gijsen,
H. J. M.; Berthelot, D. J-C.; Oehlrich, D. Triazole Derivatives as
Gamma-Secretase Modulators and Their Preparation and Use
for the Treatment of Diseases. PCT Int. Appl. WO 2011086098 A1.
(b) Kamenecka, T. M.; Jiang, R.; Song, X.; Lograsso, P.; Cameron,
M. D. Preparation of Phenylaminopyrimidine Derivatives and Analogs
as Protein Kinase Inhibitors. PCT Int. Appl. WO 2009032861. (c)
Naidu, B. N.; Connolly, T. P.; Ueda, Y. Cyclic Pyrimidinone Derivatives
as HIV Integrase Inhibitors and Their Preparation, Pharmaceutical
Compositions and Use in the Treatment of HIV Infections. U.S. Patent,
7419969.
r
10.1021/ol401428x
XXXX American Chemical Society